Affymetrix and IBM


Affymetrix and IBM have launched a collaboration designed to help clinicians integrate genomic data with patient data such as medical histories and lab tests, Affymetrix said Tuesday.

The Santa Clara, Calif.-based maker of the GeneChip microarray product line will work with IBM professional services so that data derived from analysis conducted on the company’s proprietary hardware and software platforms can be referenced with medically relevant data as well as used in regulatory compliance efforts.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.